- Home
- ATHA vs DATS Comparison
ATHA vs DATS Comparison
Compare ATHA & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- DATS
- Stock Information
- Founded
- ATHA 2011
- DATS 2014
- Country
- ATHA United States
- DATS United States
- Employees
- ATHA N/A
- DATS N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- DATS Computer Software: Prepackaged Software
- Sector
- ATHA Health Care
- DATS Technology
- Exchange
- ATHA Nasdaq
- DATS Nasdaq
- Market Cap
- ATHA 15.7M
- DATS 13.4M
- IPO Year
- ATHA 2020
- DATS 2021
- Fundamental
- Price
- ATHA $0.37
- DATS $2.23
- Analyst Decision
- ATHA Buy
- DATS
- Analyst Count
- ATHA 4
- DATS 0
- Target Price
- ATHA $11.25
- DATS N/A
- AVG Volume (30 Days)
- ATHA 293.7K
- DATS 74.9K
- Earning Date
- ATHA 08-12-2025
- DATS 08-13-2025
- Dividend Yield
- ATHA N/A
- DATS N/A
- EPS Growth
- ATHA N/A
- DATS N/A
- EPS
- ATHA N/A
- DATS N/A
- Revenue
- ATHA N/A
- DATS $388.00
- Revenue This Year
- ATHA N/A
- DATS N/A
- Revenue Next Year
- ATHA N/A
- DATS N/A
- P/E Ratio
- ATHA N/A
- DATS N/A
- Revenue Growth
- ATHA N/A
- DATS N/A
- 52 Week Low
- ATHA $0.22
- DATS $1.11
- 52 Week High
- ATHA $3.67
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- ATHA 47.14
- DATS 34.77
- Support Level
- ATHA $0.34
- DATS $2.28
- Resistance Level
- ATHA $0.51
- DATS $2.46
- Average True Range (ATR)
- ATHA 0.05
- DATS 0.14
- MACD
- ATHA -0.01
- DATS -0.04
- Stochastic Oscillator
- ATHA 25.41
- DATS 1.92
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.